Field of Expertise

With over a decade of experience across the life sciences, biotech, and medical technology sectors, Anca Haralambie is a multidisciplinary leader committed to delivering sustainable, science-backed solutions for high-risk, hygiene-critical environments.

As Founder and CEO of Aridom Sanex, she leads innovation in:

- Infection prevention and control technologies

- HOCl-based biocidal systems

- Automated dry misting and decontamination equipment

- Water purification and plastic-free hygiene alternatives

Her mission is to help industries transition toward low-toxicity, low-carbon hygiene systems, from healthcare and agriculture to cleanrooms and many more.

Additional Areas of Expertise

-  Driving business development within contract research organisations (CROs) and bioscience R&D environments

- Leading the commercialisation of advanced technologies, including stem cell platforms, organoids, and diagnostics

- Forging strategic partnerships and securing grant funding to accelerate innovation and market access

- Translating clinical needs into scalable, regulatory-compliant, and environmentally responsible solutions

- Championing the fight against antimicrobial resistance (AMR) through the adoption of safe, non-toxic hygiene technologies

- Advocating for cross-sector innovation aligned with One Health principles and net-zero sustainability goals

Expertise

Anca is a seasoned life sciences professional with over a decade of experience spanning medical sales, biotech innovation, and business development within CROs, diagnostics, and translational research. As CEO of Aridom Sanex, she leads the development of sustainable hygiene technologies, such as HOCl-based disinfection, dry misting systems, and water purification, serving healthcare, agriculture, and high-compliance industries. Passionate about tackling the global threat of antimicrobial resistance (AMR), Anca advocates for safe, non-toxic biocidal alternatives that reduce overreliance on harsh chemicals and antibiotics in hygiene protocols. Her career includes key commercial roles at pioneering bioscience companies, where she specialised in launching novel stem cell, organoid, and neuroscience technologies, forging strategic partnerships, and driving business growth across the UK and international markets.